Shl Medical
Shl Medical, a leading player in the medical device industry, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 1985, the company has established itself as a pioneer in the development of innovative drug delivery systems, particularly in the field of prefilled syringes and auto-injectors. Shl Medical's core offerings are distinguished by their focus on user-centric design and advanced technology, ensuring safety and efficacy in medication administration. With a commitment to quality and regulatory compliance, the company has achieved significant milestones, including partnerships with major pharmaceutical firms. Recognised for its expertise, Shl Medical continues to strengthen its market position, contributing to the evolution of healthcare solutions worldwide.
DitchCarbon Score
How does Shl Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shl Medical's score of 41 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shl Medical's reported carbon emissions
In 2023, SHL Medical reported total greenhouse gas emissions of approximately 43,271,000 kg CO2e for Scope 1, 440,000 kg CO2e for Scope 2, and about 246,644,000 kg CO2e for Scope 3 emissions. This represents a slight increase in Scope 1 emissions from 42,973,000 kg CO2e in 2022, while Scope 2 emissions decreased from 633,000 kg CO2e. Scope 3 emissions also saw a reduction from 254,504,000 kg CO2e in the previous year. SHL Medical has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the base year. Additionally, the company targets a 51.6% reduction in Scope 3 emissions related to purchased goods and services, employee commuting, and downstream transportation and distribution per million units sold within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with the reductions necessary to limit global warming to 1.5°C. Overall, SHL Medical is actively working towards significant emissions reductions, demonstrating a commitment to sustainability in the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 42,973,000 | 00,000,000 |
| Scope 2 | 633,000 | 000,000 |
| Scope 3 | 254,504,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shl Medical is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
